<DOC>
	<DOCNO>NCT01289015</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety NAFT-600 , apply daily 2 week , compare placebo 2 week treatment subject tinea pedis .</brief_summary>
	<brief_title>Efficacy Safety NAFT-600 Subjects With Tinea Pedis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<criteria>Males nonpregnant female , â‰¥12 year age , race sex . Females childbearing potential must negative urine pregnancy test . Presence interdigital interdigital moccasin type tinea pedis one foot characterize clinical evidence tinea infection ( least moderate erythema , moderate scaling mild pruritus ) base sign symptom affect area ( ) ) . Subjects lifethreatening condition ( ex . autoimmune deficiency syndrome , cancer , unstable angina myocardial infarction ) within last 6 month . Subjects abnormal finding physical laboratory consider investigator clinically important indicative condition might complicate interpretation study result . Subjects know hypersensitivity study drug component . Subjects recent history currently know abuse alcohol drug . Uncontrolled diabetes mellitus . Hemodialysis chronic ambulatory peritoneal dialysis therapy . Current diagnosis immunocompromising condition . Foot psoriasis , corn and/or callus involve web space , atopic contact dermatitis . Severe dermatophytoses , onychomycosis ( evaluated foot ) , mucocutaneous candidiasis bacterial skin infection . Extremely severe tinea pedis ( incapacitate ) . Female subject pregnant lactating , use agree use acceptable form contraception study , intend become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>fungal infection</keyword>
	<keyword>athlete foot</keyword>
</DOC>